PDB Short entry for 1QS4 HEADER TRANSFERASE 25-JUN-99 1QS4 TITLE CORE DOMAIN OF HIV-1 INTEGRASE COMPLEXED WITH MG++ AND 1-(5- TITLE 2 CHLOROINDOL-3-YL)-3-HYDROXY-3-(2H-TETRAZOL-5-YL)-PROPENONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (HIV-1 INTEGRASE (E.C.2.7.7.49)); COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: CATALYTIC CORE DOMAIN; COMPND 5 EC: 2.7.7.49; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS DNA INTEGRATION, INTEGRASE, HIV, ASPARTYL PROTEASE, ENDONUCLEASE, KEYWDS 2 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR Y.GOLDGUR,R.CRAIGIE,T.FUJIWARA,T.YOSHINAGA,D.R.DAVIES REVDAT 7 14-FEB-24 1QS4 1 REMARK REVDAT 6 03-NOV-21 1QS4 1 REMARK SEQADV LINK REVDAT 5 01-FEB-17 1QS4 1 AUTHOR REVDAT 4 13-JUL-11 1QS4 1 VERSN REVDAT 3 01-APR-08 1QS4 1 HEADER VERSN REVDAT 2 22-NOV-99 1QS4 1 SEQADV REVDAT 1 17-NOV-99 1QS4 0 JRNL AUTH Y.GOLDGUR,R.CRAIGIE,G.H.COHEN,T.FUJIWARA,T.YOSHINAGA, JRNL AUTH 2 T.FUJISHITA,H.SUGIMOTO,T.ENDO,H.MURAI,D.R.DAVIES JRNL TITL STRUCTURE OF THE HIV-1 INTEGRASE CATALYTIC DOMAIN COMPLEXED JRNL TITL 2 WITH AN INHIBITOR: A PLATFORM FOR ANTIVIRAL DRUG DESIGN. JRNL REF PROC.NATL.ACAD.SCI.USA V. 96 13040 1999 JRNL REFN ISSN 0027-8424 JRNL PMID 10557269 JRNL DOI 10.1073/PNAS.96.23.13040 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.07 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.2 REMARK 3 NUMBER OF REFLECTIONS : 25282 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1282 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 25 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.13 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 81.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2963 REMARK 3 BIN FREE R VALUE : 0.3287 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3469 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 23 REMARK 3 SOLVENT ATOMS : 544 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.64 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.73200 REMARK 3 B22 (A**2) : -10.30000 REMARK 3 B33 (A**2) : 5.56700 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.64400 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.190 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : BABINET'S PRINCIPLE REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 73.91 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : 100.PAR REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : 100.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1QS4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-JUN-99. REMARK 100 THE DEPOSITION ID IS D_1000009234. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JAN-99 REMARK 200 TEMPERATURE (KELVIN) : 95.0 REMARK 200 PH : 7.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26564 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 38.070 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 200 DATA REDUNDANCY : 2.120 REMARK 200 R MERGE (I) : 0.05100 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 81.2 REMARK 200 DATA REDUNDANCY IN SHELL : 1.50 REMARK 200 R MERGE FOR SHELL (I) : 0.27400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.84 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG 4000, 100 MM HEPES, 5 MM REMARK 280 MGCL2, 5 MM DTT, 1% GLYCEROL, PH 7.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 38.11650 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 23.36750 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 38.11650 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 23.36750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 2980 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13990 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -30.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE A 141 REMARK 465 PRO A 142 REMARK 465 TYR A 143 REMARK 465 ASN A 144 REMARK 465 ILE B 141 REMARK 465 PRO B 142 REMARK 465 ILE C 141 REMARK 465 PRO C 142 REMARK 465 TYR C 143 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 1018 O HOH A 1039 2.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 147 174.25 -59.07 REMARK 500 GLN A 148 -31.44 61.31 REMARK 500 PRO B 58 1.99 -65.14 REMARK 500 ASN B 117 37.63 -98.12 REMARK 500 ASN B 144 112.06 -172.13 REMARK 500 SER B 147 -19.90 166.90 REMARK 500 GLN B 168 -8.92 -58.61 REMARK 500 ASN C 117 31.66 -94.29 REMARK 500 SER C 147 8.30 58.47 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A1001 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 64 OD1 REMARK 620 2 ASP A 116 OD1 80.2 REMARK 620 3 HOH A1013 O 175.2 103.3 REMARK 620 4 HOH A1073 O 92.3 165.5 85.0 REMARK 620 5 HOH A1076 O 94.9 77.1 89.1 91.3 REMARK 620 6 HOH A1120 O 81.3 90.5 95.3 100.7 167.5 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B1002 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 64 OD1 REMARK 620 2 ASP B 116 OD1 79.6 REMARK 620 3 HOH B1092 O 80.9 67.9 REMARK 620 4 HOH B1100 O 171.4 91.9 96.7 REMARK 620 5 HOH B1118 O 86.1 96.9 161.5 94.2 REMARK 620 6 HOH B1185 O 96.7 162.8 94.9 91.7 99.7 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG C1003 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP C 64 OD1 REMARK 620 2 ASP C 116 OD1 75.6 REMARK 620 3 HOH C1023 O 74.4 75.1 REMARK 620 4 HOH C1050 O 76.3 85.4 148.0 REMARK 620 5 HOH C1103 O 165.9 104.9 92.0 117.8 REMARK 620 6 HOH C1105 O 76.8 149.3 84.7 101.0 98.6 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG B 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG C 1003 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 100 A 1004 DBREF 1QS4 A 56 209 UNP Q76353 Q76353_9HIV1 771 924 DBREF 1QS4 B 56 209 UNP Q76353 Q76353_9HIV1 771 924 DBREF 1QS4 C 56 209 UNP Q76353 Q76353_9HIV1 771 924 SEQADV 1QS4 GLU A 131 UNP Q76353 TRP 846 ENGINEERED MUTATION SEQADV 1QS4 GLY A 133 UNP Q76353 ALA 848 CONFLICT SEQADV 1QS4 LYS A 185 UNP Q76353 PHE 890 ENGINEERED MUTATION SEQADV 1QS4 GLU B 131 UNP Q76353 TRP 846 ENGINEERED MUTATION SEQADV 1QS4 GLY B 133 UNP Q76353 ALA 848 CONFLICT SEQADV 1QS4 LYS B 185 UNP Q76353 PHE 890 ENGINEERED MUTATION SEQADV 1QS4 GLU C 131 UNP Q76353 TRP 846 ENGINEERED MUTATION SEQADV 1QS4 GLY C 133 UNP Q76353 ALA 848 CONFLICT SEQADV 1QS4 LYS C 185 UNP Q76353 PHE 890 ENGINEERED MUTATION SEQRES 1 A 154 CYS SER PRO GLY ILE TRP GLN LEU ASP CYS THR HIS LEU SEQRES 2 A 154 GLU GLY LYS VAL ILE LEU VAL ALA VAL HIS VAL ALA SER SEQRES 3 A 154 GLY TYR ILE GLU ALA GLU VAL ILE PRO ALA GLU THR GLY SEQRES 4 A 154 GLN GLU THR ALA TYR PHE LEU LEU LYS LEU ALA GLY ARG SEQRES 5 A 154 TRP PRO VAL LYS THR VAL HIS THR ASP ASN GLY SER ASN SEQRES 6 A 154 PHE THR SER THR THR VAL LYS ALA ALA CYS GLU TRP GLY SEQRES 7 A 154 GLY ILE LYS GLN GLU PHE GLY ILE PRO TYR ASN PRO GLN SEQRES 8 A 154 SER GLN GLY VAL ILE GLU SER MET ASN LYS GLU LEU LYS SEQRES 9 A 154 LYS ILE ILE GLY GLN VAL ARG ASP GLN ALA GLU HIS LEU SEQRES 10 A 154 LYS THR ALA VAL GLN MET ALA VAL PHE ILE HIS ASN LYS SEQRES 11 A 154 LYS ARG LYS GLY GLY ILE GLY GLY TYR SER ALA GLY GLU SEQRES 12 A 154 ARG ILE VAL ASP ILE ILE ALA THR ASP ILE GLN SEQRES 1 B 154 CYS SER PRO GLY ILE TRP GLN LEU ASP CYS THR HIS LEU SEQRES 2 B 154 GLU GLY LYS VAL ILE LEU VAL ALA VAL HIS VAL ALA SER SEQRES 3 B 154 GLY TYR ILE GLU ALA GLU VAL ILE PRO ALA GLU THR GLY SEQRES 4 B 154 GLN GLU THR ALA TYR PHE LEU LEU LYS LEU ALA GLY ARG SEQRES 5 B 154 TRP PRO VAL LYS THR VAL HIS THR ASP ASN GLY SER ASN SEQRES 6 B 154 PHE THR SER THR THR VAL LYS ALA ALA CYS GLU TRP GLY SEQRES 7 B 154 GLY ILE LYS GLN GLU PHE GLY ILE PRO TYR ASN PRO GLN SEQRES 8 B 154 SER GLN GLY VAL ILE GLU SER MET ASN LYS GLU LEU LYS SEQRES 9 B 154 LYS ILE ILE GLY GLN VAL ARG ASP GLN ALA GLU HIS LEU SEQRES 10 B 154 LYS THR ALA VAL GLN MET ALA VAL PHE ILE HIS ASN LYS SEQRES 11 B 154 LYS ARG LYS GLY GLY ILE GLY GLY TYR SER ALA GLY GLU SEQRES 12 B 154 ARG ILE VAL ASP ILE ILE ALA THR ASP ILE GLN SEQRES 1 C 154 CYS SER PRO GLY ILE TRP GLN LEU ASP CYS THR HIS LEU SEQRES 2 C 154 GLU GLY LYS VAL ILE LEU VAL ALA VAL HIS VAL ALA SER SEQRES 3 C 154 GLY TYR ILE GLU ALA GLU VAL ILE PRO ALA GLU THR GLY SEQRES 4 C 154 GLN GLU THR ALA TYR PHE LEU LEU LYS LEU ALA GLY ARG SEQRES 5 C 154 TRP PRO VAL LYS THR VAL HIS THR ASP ASN GLY SER ASN SEQRES 6 C 154 PHE THR SER THR THR VAL LYS ALA ALA CYS GLU TRP GLY SEQRES 7 C 154 GLY ILE LYS GLN GLU PHE GLY ILE PRO TYR ASN PRO GLN SEQRES 8 C 154 SER GLN GLY VAL ILE GLU SER MET ASN LYS GLU LEU LYS SEQRES 9 C 154 LYS ILE ILE GLY GLN VAL ARG ASP GLN ALA GLU HIS LEU SEQRES 10 C 154 LYS THR ALA VAL GLN MET ALA VAL PHE ILE HIS ASN LYS SEQRES 11 C 154 LYS ARG LYS GLY GLY ILE GLY GLY TYR SER ALA GLY GLU SEQRES 12 C 154 ARG ILE VAL ASP ILE ILE ALA THR ASP ILE GLN HET MG A1001 1 HET 100 A1004 20 HET MG B1002 1 HET MG C1003 1 HETNAM MG MAGNESIUM ION HETNAM 100 1-(5-CHLOROINDOL-3-YL)-3-HYDROXY-3-(2H-TETRAZOL-5-YL)- HETNAM 2 100 PROPENONE FORMUL 4 MG 3(MG 2+) FORMUL 5 100 C12 H8 CL N5 O2 FORMUL 8 HOH *544(H2 O) HELIX 1 1 THR A 93 GLY A 106 1 14 HELIX 2 2 GLY A 118 SER A 123 1 6 HELIX 3 3 SER A 123 GLY A 133 1 11 HELIX 4 4 GLN A 148 ARG A 166 1 19 HELIX 5 5 ASP A 167 ALA A 169 5 3 HELIX 6 6 HIS A 171 LYS A 186 1 16 HELIX 7 7 SER A 195 ASP A 207 1 13 HELIX 8 8 THR B 93 TRP B 108 1 16 HELIX 9 9 GLY B 118 SER B 123 1 6 HELIX 10 10 SER B 123 GLY B 134 1 12 HELIX 11 11 GLY B 149 ARG B 166 1 18 HELIX 12 12 HIS B 171 LYS B 186 1 16 HELIX 13 13 ARG B 187 ILE B 191 5 5 HELIX 14 14 SER B 195 ILE B 208 1 14 HELIX 15 15 THR C 93 TRP C 108 1 16 HELIX 16 16 GLY C 118 SER C 123 1 6 HELIX 17 17 SER C 123 GLY C 134 1 12 HELIX 18 18 GLY C 149 ARG C 166 1 18 HELIX 19 19 ASP C 167 ALA C 169 5 3 HELIX 20 20 HIS C 171 LYS C 186 1 16 HELIX 21 21 ARG C 187 ILE C 191 5 5 HELIX 22 22 SER C 195 GLN C 209 1 15 SHEET 1 A 5 ILE A 84 ILE A 89 0 SHEET 2 A 5 LYS A 71 HIS A 78 -1 O VAL A 72 N ILE A 89 SHEET 3 A 5 ILE A 60 LEU A 68 -1 O GLN A 62 N VAL A 77 SHEET 4 A 5 THR A 112 HIS A 114 1 O THR A 112 N TRP A 61 SHEET 5 A 5 LYS A 136 GLU A 138 1 O LYS A 136 N VAL A 113 SHEET 1 B 5 ILE B 84 ILE B 89 0 SHEET 2 B 5 LYS B 71 HIS B 78 -1 O VAL B 72 N ILE B 89 SHEET 3 B 5 ILE B 60 LEU B 68 -1 O GLN B 62 N VAL B 77 SHEET 4 B 5 THR B 112 THR B 115 1 O THR B 112 N TRP B 61 SHEET 5 B 5 LYS B 136 PHE B 139 1 O LYS B 136 N VAL B 113 SHEET 1 C 5 ILE C 84 ILE C 89 0 SHEET 2 C 5 LYS C 71 HIS C 78 -1 O VAL C 72 N ILE C 89 SHEET 3 C 5 ILE C 60 LEU C 68 -1 O GLN C 62 N VAL C 77 SHEET 4 C 5 THR C 112 THR C 115 1 O THR C 112 N TRP C 61 SHEET 5 C 5 LYS C 136 PHE C 139 1 O LYS C 136 N VAL C 113 LINK OD1 ASP A 64 MG MG A1001 1555 1555 2.32 LINK OD1 ASP A 116 MG MG A1001 1555 1555 2.25 LINK MG MG A1001 O HOH A1013 1555 1555 2.44 LINK MG MG A1001 O HOH A1073 1555 1555 2.36 LINK MG MG A1001 O HOH A1076 1555 1555 2.32 LINK MG MG A1001 O HOH A1120 1555 1555 2.30 LINK OD1 ASP B 64 MG MG B1002 1555 1555 2.37 LINK OD1 ASP B 116 MG MG B1002 1555 1555 2.34 LINK MG MG B1002 O HOH B1092 1555 1555 2.53 LINK MG MG B1002 O HOH B1100 1555 1555 2.47 LINK MG MG B1002 O HOH B1118 1555 1555 2.53 LINK MG MG B1002 O HOH B1185 1555 1555 2.49 LINK OD1 ASP C 64 MG MG C1003 1555 1555 2.59 LINK OD1 ASP C 116 MG MG C1003 1555 1555 2.43 LINK MG MG C1003 O HOH C1023 1555 1555 2.49 LINK MG MG C1003 O HOH C1050 1555 1555 2.30 LINK MG MG C1003 O HOH C1103 1555 1555 2.56 LINK MG MG C1003 O HOH C1105 1555 1555 2.36 SITE 1 AC1 6 ASP A 64 ASP A 116 HOH A1013 HOH A1073 SITE 2 AC1 6 HOH A1076 HOH A1120 SITE 1 AC2 6 ASP B 64 ASP B 116 HOH B1092 HOH B1100 SITE 2 AC2 6 HOH B1118 HOH B1185 SITE 1 AC3 6 ASP C 64 ASP C 116 HOH C1023 HOH C1050 SITE 2 AC3 6 HOH C1103 HOH C1105 SITE 1 AC4 10 ASP A 64 CYS A 65 THR A 66 GLN A 148 SITE 2 AC4 10 ILE A 151 GLU A 152 ASN A 155 LYS A 156 SITE 3 AC4 10 LYS A 159 HOH A1120 CRYST1 76.233 46.735 141.361 90.00 105.55 90.00 C 1 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013118 0.000000 0.003650 0.00000 SCALE2 0.000000 0.021397 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007343 0.00000